Global Stem Cell Therapy Market 2018-2022
About Stem Cell Therapy
Stem cells are cells that have the ability to divide and differentiate into almost every cell type in the body and used in surgery and medicine.
Technavio’s analysts forecast the Global Stem Cell Therapy Market to grow at a CAGR of 10.52% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the stem cell therapy market. To calculate the market size, the report considers the revenue generated by the application of stem cell therapy across the globe.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report - Global Stem Cell Therapy Market 2018-2022
Technavio recognizes the following companies as the key players in the global stem cell therapy market: Gilead, Novartis, Organogenesis, and Vericel.
Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the rising cost of stem cell therapy procedure. Stem cell transportation is a costly procedure and requires highly specialized tools and resources.”
According to the report, one driver influencing this market is the driven by the increasing awareness about stem cell therapy across the globe. Stem cells are cells that have the ability to divide and differentiate into almost every cell type in the body and used in surgery and medicine. With increasing advances in stem cell therapy research, the demand for stem cell therapy procedure is expected to witness a rise over the next few years.
Further, the report states that one challenge affecting this market is the high cost of clinical trials. The high cost of conducting clinical trials on stem cell therapy is high which poses a critical challenge to the growth of the market.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook